biosimilarsforum.org
homepage - biosimilars forumthe biosimilars forum is a nonprofit organization founded to advance biosimilars in the united states and expand access and availability of biological medicines.
Known alternatives and similar websites from available relationship data, with available traffic and value estimates.
Website title: Biosimilars | An Obvious Solution to Lowering U.S. Health Care
Competitor lists are based on existing similarity relationships. A similar website is not necessarily a direct business competitor.
Missing figures are shown as unavailable, not as zero.
Swipe the table to compare metrics. Website names stay visible while you scroll.
| Website | Estimated worth | Monthly visits (est.) | Monthly pageviews (est.) | Report |
|---|---|---|---|---|
Bbiosimilarsforum.org
homepage - biosimilars forum | $1.2K | 2.5K | 3.9K | |
Aaccessiblemeds.org
Generics & Biosimilars | Association for Accessible Medicines | $10.7K | 10.3K | 16.6K | |
Ccreativebiolabs.net
Recombinant Antibodies & High-Throughput Antibody Production Services - Creative Biolabs | $3.2K | 20.2K | 32.3K | |
Ppharmis.org
Pharmaceutical Structure Database. Tokyo University of Pharmacy and Life Sciences – Biosimilars, Recombinant proteins, Chiral molecules, Capilia | $867 | 1.5K | 2.4K | |
Bbiosimilars-europe.com
Biosimilars | $694 | 4.5K | 7.2K | |
Hhealthybiologics.org
Biosimilars - 50-State Network | $484 | 874 | 1.4K |
the biosimilars forum is a nonprofit organization founded to advance biosimilars in the united states and expand access and availability of biological medicines.
The Association for Accessible Medicines (AAM) works to ensure that more generic and biosimilar medicines are accessible to more people who need them.
Explore Creative Biolabs' dedicated platform for Recombinant Antibodies (Human, Rabbit, NHP, Model Organisms) and High-throughput Production. We provide industrial-grade CDMO solutions and AbPlus™ products exclusively for research applications.
Pharmaceutical Structure Database. Tokyo University of Pharmacy and Life Sciences - Biosimilars, Recombinant proteins, Chiral molecules, Capilia
biosimilars, biobetters, biologics, smi group, smi pharma, biosimilars conference, biosimilars congress, biosimilars 2019, michel mikhail, commercial biosimilars, interchangeability
A new class of treatments that can help lower healthcare costs.
Similar-site relationships are taken from the legacy Siteprice dataset where available. The estimated value, visits and pageviews shown alongside those sites are drawn from the current Website estimates when a matching domain record exists.
The presence of a competitor is not a verified business relationship, and the absence of a figure doesn't mean the website has no traffic or value.